CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 100 filers reported holding CUE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,238 | -32.7% | 31,410 | +6.9% | 0.00% | – |
| Q2 2023 | $107,280 | -30.8% | 29,392 | -7.5% | 0.00% | – |
| Q1 2022 | $155,000 | -56.9% | 31,768 | -0.1% | 0.00% | – |
| Q4 2021 | $360,000 | -23.7% | 31,804 | -1.9% | 0.00% | -100.0% |
| Q3 2021 | $472,000 | +30.7% | 32,414 | +4.5% | 0.00% | – |
| Q2 2021 | $361,000 | -10.6% | 31,014 | -6.3% | 0.00% | -100.0% |
| Q1 2021 | $404,000 | -7.6% | 33,092 | -5.3% | 0.00% | 0.0% |
| Q4 2020 | $437,000 | -15.0% | 34,933 | +2.3% | 0.00% | 0.0% |
| Q3 2020 | $514,000 | -41.6% | 34,163 | -4.8% | 0.00% | 0.0% |
| Q2 2020 | $880,000 | +151.4% | 35,893 | +45.7% | 0.00% | 0.0% |
| Q1 2020 | $350,000 | -8.9% | 24,631 | +1.8% | 0.00% | 0.0% |
| Q4 2019 | $384,000 | +93.0% | 24,206 | +2.4% | 0.00% | – |
| Q3 2019 | $199,000 | -5.2% | 23,630 | +1.0% | 0.00% | – |
| Q2 2019 | $210,000 | +19.3% | 23,405 | +2.7% | 0.00% | – |
| Q1 2019 | $176,000 | +64.5% | 22,792 | -0.0% | 0.00% | – |
| Q4 2018 | $107,000 | -21.3% | 22,795 | +51.3% | 0.00% | – |
| Q3 2018 | $136,000 | -27.7% | 15,071 | -5.1% | 0.00% | – |
| Q2 2018 | $188,000 | – | 15,875 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |